Janssen Pharmaceuticals, Inc. v. Tolmar, Inc.

Case: 24-1699 Document: 36 Page: 1 Filed: 05/05/2026

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ JANSSEN PHARMACEUTICALS, INC., JANSSEN PHARMACEUTICA NV, Plaintiffs-Cross-Appellants v. TOLMAR, INC., Defendant-Appellant ______________________ 2024-1699, 2024-1700, 2024-1980, 2024-2020 ______________________ Appeals from the United States District Court for the District of Delaware in No. 1:21-cv-01784-WCB-SRF, Cir- cuit Judge William C. Bryson. ______________________ ON MOTION ______________________ Before LOURIE, TARANTO, and CHEN, Circuit Judges.

PER CURIAM.

ORDER Having “agreed to resolve all claims between them” in this matter, ECF No. 34 at 7, the parties jointly move to remand these appeals in light of the district court’s April 3, 2026 indicative ruling that it would vacate its March 13, Case: 24-1699 Document: 36 Page: 2 Filed: 05/05/2026

2 JANSSEN PHARMACEUTICALS, INC. v. TOLMAR, INC.

2024 final judgment and enter a consent judgment if this court remanded.

This court takes no position on the propriety or neces- sity of any vacatur, leaving it to the district court to con- sider the principles enunciated in United States Bancorp Mortgage Co. v. Bonner Mall Partnership, 513 U.S. 18, 29 (1994).

Accordingly, IT IS ORDERED THAT: (1) The motion is granted to the extent that the ap- peals are remanded. (2) Each side shall bear its own costs.

FOR THE COURT

May 5, 2026 Date ISSUED AS A MANDATE: May 5, 2026